Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does extended-release somatostatin slow the growth of renal cysts in autosomal-dominant polycystic kidney disease?

Nature Clinical Practice Nephrology volume 2, pages 66–67 (2006)Cite this article

boxed-textRuggenenti P et al. (2005) Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease. Kidney Int 68: 206–216

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Gattone VH Jr et al. (2003) Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med 9: 1323–1326

    Article  CAS  Google Scholar 

  2. Wang X et al. (2005) Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J Am Soc Nephrol 16: 846–851

    Article  CAS  Google Scholar 

  3. Torres VE et al. (2004) Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat Med 10: 363–364

    Article  CAS  Google Scholar 

  4. Chapman AB et al. (2003) Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int 64: 1035–1045

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloe Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Kansas University Medical Center, Kansas City, KS, USA

    Jared J Grantham

Authors
  1. Jared J Grantham
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jared J Grantham.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grantham, J. Does extended-release somatostatin slow the growth of renal cysts in autosomal-dominant polycystic kidney disease?. Nat Rev Nephrol 2, 66–67 (2006). https://doi.org/10.1038/ncpneph0082

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0082

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing